GlassScriptPhysician profile
David Gordon Currie
NPI 1811316490
$8,966.78
in general payments reported to CMS, 2019-2025
29 companies · $2,727 in 2025
The $2,727 reported for 2025 was more than what 87% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $309 · 2020: $624 · 2021: $56.20 · 2022: $3,389 · 2023: $1,164 · 2024: $697 · 2025: $2,727.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,447 · Travel and Lodging: $1,142.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,446.59 |
| Travel and Lodging | $1,141.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,151.76 | 2019-2025 | Proclaim |
| Spinal Simplicity, LLC | $1,208.09 | 2022-2025 | Ha Minuteman G3-R |
| Boston Scientific Corporation | $1,138.82 | 2019-2025 | General - Vascular Intervention, Wavewriter Alpha Prime 16, Avista Mri |
| Medtronic, INC. | $832.49 | 2022-2025 | Intellis Adaptivestim, Inceptiv |
| Relievant Medsystems, INC. | $738.90 | 2020-2023 | Intracept |
| Collegium Pharmaceutical, INC. | $258.12 | 2022-2024 | Xtampza, Belbuca |
| Nevro Corp. | $221.18 | 2022-2024 | Senza |
| Globus Medical, INC. | $215.13 | 2025 | Senza, Omnia |
| Curonix LLC | $165.31 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $126.07 | 2022 | |
| Nalu Medical, INC. | $118.68 | 2023-2024 | Nalu Neurostimulation System |
| Averitas Pharma INC. | $109.61 | 2023-2024 | Qutenza |
| Scilex Pharmaceuticals INC. | $76.56 | 2022 | |
| Abbvie INC. | $72.35 | 2022-2025 | Ubrelvy |
| Tersera Therapeutics LLC | $71.00 | 2022 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertos Medical, INC. | $66.82 | 2021-2024 | Mild Device Kit |
| Medtronic USA, INC. | $61.75 | 2019 | |
| Spr Therapeutics, INC | $55.09 | 2022-2024 | Sprint Pns System |
| Grt US Holding, INC. | $50.26 | 2022 | |
| Impactortho, INC. | $45.32 | 2022 | |
| Valinor Pharma, LLC | $36.46 | 2024 | Movantik |
| Almatica Pharma LLC | $29.98 | 2022 | |
| B. Braun Medical INC. | $28.71 | 2025 | Pencan |
| Vertex Pharmaceuticals Incorporated | $19.10 | 2025 | |
| Sanofi-Aventis U.S. LLC | $15.49 | 2023 | |
| Stratus Medical, LLC | $15.45 | 2022 | |
| Merit Medical Systems INC | $14.28 | 2025 | Star Tumor Ablation System |
| Itamar Medical INC | $12.14 | 2023 | Watchpatone |
| Ferring Pharmaceuticals INC. | $11.86 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Currie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.